Literature DB >> 12527988

Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study.

B Casanova1, M C Martínez-Bisbal, C Valero, B Celda, L Martí-Bonmatí, A Pascual, L Landente, F Coret.   

Abstract

OBJECTIVE: Wallerian degeneration in normal appearing white matter in early relapsing-remitting multiple sclerosis (RRMS), and its correlation with the number of relapses and disease duration. Background Recent pathological studies have demonstrated Wallerian degeneration in normal appearing white matter (NAWM) in multiple sclerosis (MS), in established RRMS, and in chronic MS. However, the presence of Wallerian degeneration early in the disease and its correlation with relapse and with disease duration has not been studied.
METHODS: We performed proton magnetic resonance spectroscopic imaging in 21 MS patients, and 4 healthy controls, age and gender matched, aged under 45 years, with a maximum of 4 years since first bout, and an EDSS score of less than 3.0. N-acetyl-aspartate (NAA) (an index of axonal integrity) was measured in the NAWM from the pons and the cerebellar peduncles.
RESULTS: We observed that the NAA levels were abnormally low in the NAWM in the early RRMS patients (p = 0.04, Student's t-test). The decrease in the NAA concentration correlated with disease duration in the two areas studied (p = 0.03 for pons and p = 0.04 for cerebellar peduncle); and with the number of previous relapses (Pearson's correlation = -0.582, p < 0.002).
CONCLUSION: Wallerian degeneration measured by the NAA concentration at pons and cerebellar peduncles is present early in the disease and correlates with the number of relapses and disease duration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527988     DOI: 10.1007/s00415-003-0928-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging.

Authors:  M Xie; Q Wang; T-H Wu; S-K Song; S-W Sun
Journal:  Neuroscience       Date:  2011-09-25       Impact factor: 3.590

2.  An observation of interest relative to the practice of spectroscopic measurements in multiple sclerosis.

Authors:  Ana Maria Pascual; Isabel Boscá; Bonaventura Casanova; M Carmen Martinez-Bisbal; Bernardo Celda; Francisco Coret; Luis Marti-Bonmati
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

3.  Impact of the acquisition protocol on the sensitivity to demyelination and axonal loss of clinically feasible DWI techniques: a simulation study.

Authors:  Stefania Oliviero; Cosimo Del Gratta
Journal:  MAGMA       Date:  2021-01-08       Impact factor: 2.310

Review 4.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

Review 5.  Thalamus pathology in multiple sclerosis: from biology to clinical application.

Authors:  Markus Kipp; Nina Wagenknecht; Cordian Beyer; Sebastian Samer; Jens Wuerfel; Omid Nikoubashman
Journal:  Cell Mol Life Sci       Date:  2014-11-23       Impact factor: 9.261

6.  (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.

Authors:  Paul E Sijens; Jop P Mostert; Matthijs Oudkerk; Jacques De Keyser
Journal:  Eur Radiol       Date:  2005-07-19       Impact factor: 5.315

Review 7.  Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers.

Authors:  M P Kurnellas; K C Donahue; S Elkabes
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

8.  Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging.

Authors:  Amanda F Mejia; Elizabeth M Sweeney; Blake Dewey; Govind Nair; Pascal Sati; Colin Shea; Daniel S Reich; Russell T Shinohara
Journal:  Neuroimage       Date:  2015-12-28       Impact factor: 6.556

9.  Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.

Authors:  M Tiberio; D T Chard; D R Altmann; G Davies; C M Griffin; M A McLean; W Rashid; J Sastre-Garriga; A J Thompson; D H Miller
Journal:  J Neurol       Date:  2005-11-24       Impact factor: 4.849

10.  Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.

Authors:  Shailender Singh; Imke Metz; Sandra Amor; Paul van der Valk; Christine Stadelmann; Wolfgang Brück
Journal:  Acta Neuropathol       Date:  2013-01-26       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.